AbGn-108

N/A

Report date: 2025/03/14 16:53:41

Base Information

Drug NameAbGn-108

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAltrubio Inc

China Registration ClassN/A

Develop Information

Active CompaniesAltrubio Inc

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A